SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.

   Microcap & Penny StocksTLT.v


Previous 10 Next 10 
To: 3bar who wrote (1281)5/7/2019 9:54:00 AM
From: 3bar
   of 1459
 
Rutherrin® technology is patent pending in the United States, the European Union, Brazil, Russia, India and China. These countries account for approximately 65% of the world’s Gross Domestic Product (“GDP“) (2015 statistics). If patents are allowed to issue in these countries, the Rutherrin® technology will be able to be fully commercialized and protected in these major medical markets.


From the original on US patent .


Seems like the China and US trade deal will eliminate or address it .

Share RecommendKeepReplyMark as Last Read


From: 3bar5/8/2019 8:24:29 AM
   of 1459
 
For me the most important thought in my DD is that the first phase was only to see if humans could safely tolerate the compound .

100 % kill/stop of progression was not the type of results expected except from the most optimistic .

Imagine the scientists " holy jeepers Willy it works " .

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: 3bar5/10/2019 9:13:42 AM
   of 1459
 
Points of interest about the trial . stockhouse.com

Share RecommendKeepReplyMark as Last Read


From: 3bar5/10/2019 10:09:30 AM
   of 1459
 
The trial . clinicaltrials.gov

Share RecommendKeepReplyMark as Last Read


From: 3bar5/10/2019 3:29:24 PM
   of 1459
 
Best guess of what is ahead for TLT.v short term .

stockhouse.com

Share RecommendKeepReplyMark as Last Read


From: 3bar5/11/2019 4:14:39 AM
   of 1459
 
Interview with Charlie Munger legend investor . youtube.com

Share RecommendKeepReplyMark as Last Read


From: 3bar5/11/2019 5:06:40 PM
   of 1459
 
Little bit of cheer leading but maybe a lot of understanding . stockhouse.com

Share RecommendKeepReplyMark as Last Read


From: 3bar5/16/2019 5:14:00 PM
   of 1459
 
Some excellent DD from posters at shockhouse .

stockhouse.com

Share RecommendKeepReplyMark as Last Read


To: 3bar who wrote (1283)5/20/2019 7:18:00 PM
From: 3bar
   of 1459
 
Another one of the key essentials in DD here is the facts around Photofrin and even Radachlorin and how they relate back to TLT .

Photofrin got FDA approval in the 90's the lead investigator on the Canadian trials is running the Canadian trials for TLT . He says all problems with Photofrin have been corrected and improved on by TLT .

Radachlorin actually worked well had approval but had to be applied through the blood stream and so never caught on as a treatment , side effects with these early generations were a problem .

TLT has a lock on this Photo Dynamic Treatment treatment and it has proven to work .

There are maybe another 4 to 5 key DD facts to consider .

Share RecommendKeepReplyMark as Last Read


From: 3bar5/24/2019 3:57:15 PM
   of 1459
 
The phase 11 trial .

stockhouse.com

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10